{
    "clinical_study": {
        "@rank": "109113", 
        "arm_group": [
            {
                "arm_group_label": "Cross over Oxytocin and Placebo", 
                "arm_group_type": "Other", 
                "description": "FMRI measurement and blood examinations after 26 IU Oxytocin (Syntocinon)or placebo on two consecutive days"
            }, 
            {
                "arm_group_label": "Cross over Placebo and Oxytocin", 
                "arm_group_type": "Other", 
                "description": "FMRI measurement and blood examinations after 26 IU Oxytocin (Syntocinon)or placebo on two consecutive days"
            }
        ], 
        "brief_summary": {
            "textblock": "This study aims to examine the modulation of neuronal and behavioural parameters of social\n      reinforcement learning."
        }, 
        "brief_title": "Modulation of Reinforcement Learning", 
        "completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Impact of Oxytocin on Social Learning", 
        "condition_browse": {
            "mesh_term": "Child Development Disorders, Pervasive"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age between 18 and 25 years\n\n          -  male\n\n          -  IQ>80\n\n          -  written informed consent\n\n          -  proband understands character, extent and individual consequences of the study\n\n          -  competent persons who are able to follow the instructions of the study\n             personnel\n\n          -  for ASD patients: assured ASD diagnosis, comply of the ASD criteria ADI-R/ADOS-G\n\n        Exclusion Criteria:\n\n          -  prosopagnosia\n\n          -  anaphylaxis of oxytocin or other chemical substances\n\n          -  metal inside the body or other contraindications of mri scan\n\n          -  physical illness which can affect the examinations or endanger the proband\n\n          -  actual or assumed drug or alcohol abuse\n\n          -  persons who are accommodated in an institution because of court or administrative\n             order\n\n          -  persons with a relationship of dependence to the sponsor or investigator\n\n          -  healthy probands: psychiatric disorder according to ICD-10-WHO F at the moment and in\n             history, continuous drug-intake at time of measurements\n\n          -  patients with ASD: psychiatric disorder according to ICD-10-WHO F (except ASD\n             disorder in patient group) during the last 12 month being not treated, continuous\n             drug-intake at time of measurements (psychotropic medication), exception: stimulants\n             used for treatment of attention disorders, if they can come off for the measurements"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "25 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 15, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01712464", 
            "org_study_id": "12-033"
        }, 
        "intervention": {
            "arm_group_label": [
                "Cross over Oxytocin and Placebo", 
                "Cross over Placebo and Oxytocin"
            ], 
            "description": "FMRI measurement and blood examinations after 26 IU Oxytocin (Syntocinon)or placebo on two consecutive days", 
            "intervention_name": "Oxytocin vs. Placebo", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Oxytocin"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 21, 2013", 
        "location": {
            "contact": {
                "email": "mschulte@ukaachen.de", 
                "last_name": "Martin Schulte-R\u00fcther, Dr. rer. nat.", 
                "phone": "+49 241 80 89892"
            }, 
            "facility": {
                "address": {
                    "city": "Aachen", 
                    "country": "Germany", 
                    "state": "Northrhine-Westfalia", 
                    "zip": "52074"
                }, 
                "name": "Universtiy Hospital Aachen"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "2", 
        "official_title": "Modulation of Reinforcement Learning and Neuronal Activation in Ventral Stratum by Oxytocin - a Pilot Study at Autism Spectrum Disorder", 
        "overall_contact": {
            "email": "mschulte@ukaachen.de", 
            "last_name": "Martin Schulte-R\u00fchter, Dr. rer. nat.", 
            "phone": "+49 241 80 89892"
        }, 
        "overall_official": {
            "affiliation": "University Hospital, Aachen", 
            "last_name": "Martin Schulte-R\u00fcther, Dr. rer. nat", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Germany: Federal Institute for Drugs and Medical Devices", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "during social learning at one treatment with oxytocin vs placebo", 
            "measure": "Bold Signal in nucleus accumbens", 
            "safety_issue": "No", 
            "time_frame": "1 Day"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01712464"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "during social learning at one treatment with oxytocin vs placebo", 
            "measure": "Bold signal in ventral tegmental areal", 
            "safety_issue": "No", 
            "time_frame": "1 Day"
        }, 
        "source": "RWTH Aachen University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "RWTH Aachen University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2012", 
        "study_design": "Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "May 2013"
    }
}